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ABSTRACT
The topology and dynamics of the scanning riboso-
mal 43S pre-initiation complex (PIC) bound to mRNA
and initiation factors (eIFs) are probably the least un-
derstood aspects of translation initiation in eukary-
otes. Recently, we described a trapping mechanism
in alphavirus that stalls the PIC during scanning of
viral mRNA. Using this model, we were able to snap-
shot for the first time the eIF4A helicase bound to
mRNA in a 48S initiation complex assembled in vitro.
This interaction was only detected in the presence of
the natural stem loop structure (DLP) located down-
stream from the AUG in viral mRNA that promoted
stalling of the PIC, suggesting that DLP stability was
enough to jam the helicase activity of eIF4A in a frac-
tion of assembled 48S complexes. However, a sub-
stantial proportion of DLP mRNA molecules were ef-
fectively unwound by eIF4A in vitro, an activity that
alphaviruses counteract in infected cells by exclud-
ing eIF4A from viral factories. Our data indicated that
eIF4A–mRNA contact occurred in (or near) the ES6S
region of the 40S subunit, suggesting that incoming
mRNA sequences penetrate through the ES6S region
during the scanning process. We propose a topologi-
cal model of the scanning PIC and how some viruses
have exploited this topology to translate their mR-
NAs with fewer eIF requirements.
INTRODUCTION
Translation initiation in eukaryotes is a multistep process
that involves activation of the mRNA, attachment of the
ribosomal pre-initiation complex (43S PIC), and for most
mRNAs, 3′ movement (‘scanning’) of the PIC to locate
the initiation codon (48S complex formation), necessary for
60S subunit binding (1). This process is assisted by a set
of initiation factors (eIFs) that work cooperatively through
a coordinated chain of interactions. The eIF4F complex
(eIF4E+4A+4G) is mainly involved in mRNA activation,
attachment and scanning, whereas eIF2 bound to Met-
tRNA and GTP (ternary complex), eIF5, eIF1 and eIF1A
are mainly involved in recognition of the initiation codon.
eIF3, a multiprotein complex that encircles 40S, is involved
in almost every step of translation initiation (2–4). The pro-
portion of PICs that reach the initiation codon is variable,
directly related to the complexity of secondary structures in
the 5′-UTR of mRNA that must be removed (5–9). Scan-
ning of the 43S PIC requires the participation of RNA heli-
cases that convert the incoming RNA into a single-stranded
form for proper codon inspection in the decoding groove
of 40S (10). eIF4A is the canonical RNA helicase, that as-
sociates with eIF4E and eIF4G to bind near the 5′ end of
mRNA, promoting 43S loading and the subsequent scan-
ning process (11–14). Helicase activity of eIF4A is highly
stimulated by eIF4G binding that clamps the two domains
of eIF4A, thus increasing the affinity for RNA and adeno-
sine triphosphate (ATP) (15). It is thought that eIF4A pro-
motes unidirectional (toward 3′) scanning of the 43S com-
plex by alternating cycles of binding and dissociation from
mRNA in an ATP-dependent manner, and although the
topology of PIC scanning has not been determined yet, two
models have been proposed. In the first model, the eIF4F
complex is placed ahead of the 43S PIC, unwinding incom-
ing RNA structures while pulling the complex toward the
3′ end (15). In the second model, eIF4A acts as a simple
RNA clamp at the trailing edge, pushing the 43S PIC (16).
Mapping the exact placement of eIF4F within the scanning
PIC should definitely clarify this issue, though the presum-
ably dynamic nature of 43S/mRNA/eIF4F interactions has
severely limited the ability of cryo-EM techniques to recon-
struct the whole 48S initiation complex (17–20). Moreover,
no stable interaction has been detected between eIF4A and
mRNA sequences within the 48S complex.
The study of alphavirus (Sindbis (SV) and Semliki For-
est (SFV)) mRNA translation has recently revealed how the
secondary structure (DLP) located 25–37 nt downstream
from the AUG of viral 26S mRNA can influence recogni-
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tion of the initiation codon, stalling advance of the scan-
ning PIC by interacting with the ES6S region of the 40S
subunit (21,22). This RNA trapping mechanism has been
interpreted as an adaptation of these viruses to enable trans-
lation initiation even when eIF2 becomes inactivated by
protein kinase R in vertebrate hosts (23,24). Under these
circumstances, it is not clear how the Met-tRNAi can be
transferred to the initiation complex of viral 26S mRNA.
The participation of alternative eIFs as eIF2A, eIF2D and
eIF5B has been suggested, although the possibility that
Met-tRNAi could enter the complex by simple diffusion,
perhaps with the help of some viral product(s), is still open
(24–26). In this work, we used this feature of alphavirus
mRNA to snapshot the scanning complex in vitro, which
allowed us to detect the contacts of eIF4A with mRNA in
ES6S region of 40S subunit.
MATERIALS AND METHODS
Synthesis of mRNA
Minimal versions of SV and SFV mRNAs with U residues
at defined positions were synthesized in vitro by T7 RNA
polymerase (NEB) in the presence of 4-thio-UTP (4-thio-
U) as described recently (21). The transcription mixture
also included 30 Ci [-32P]GTP, and the resulting mR-
NAs were purified through Chromaspin-30 columns (Clon-
tech). Condensed versions of SV 26S mRNA encoding only
capsid protein but with the 5′ and 3′ UTRs from natural
26S mRNA were prepared (SV DLP-capsid and SV DLP-
capsid). These mRNAs were synthesized using transcrip-
tion and capping kits from NEB (HiScribe T7 Quick, Vac-
cinia capping system).
Recombinant viruses and infection
SV-eIF4A virus was constructed by cloning the hu-
man eIF4AI gene into the pTE/5′2J infectious clone,
such that the heterologous gene is transcribed from a





polymerase chain reaction product was cloned into the
pTE/5′2J-EGFP plasmid (21) using NotI and ApaI, such
that the EGFP gene was replaced with eIF4AI. We also
included the SFV DLP structure downstream from the
AUG of heterologous mRNA to improve its translation in
infected cells. Plasmids were linearized with XhoI enzyme
and transcribed in vitro with SP6 RNA polymerase (NEB)
in the presence of a cap analog (7methyl-GTP, Promega),
which typically generates mRNAs that are 50–60% capped.
About 3 g of in vitro-synthesized SV RNA was electro-
porated into ∼107 BHK21 cells, and virus was recovered
after cytopathic effect was complete. Recombinant viruses
were further amplified in BHK21 cells and purified on a
sucrose cushion as described previously (21). For virus
infections, mouse BHK21 and 3T3 cells were infected with
the indicated viruses at a multiplicity of infection (MOI) of
25 pfu/cell in 24-well plates and analyzed at 5–6 hpi.
UV crosslinking experiments
Crosslinking experiments using [32P]-labeled mRNAs with
photoreactive 4-thio-U were carried out as described re-
cently (21). After crosslinking, lysates were centrifuged over
a 20% sucrose cushion at 90 000 × g for 3 h, and the
whole ribosomal fraction (WRF) was resuspended in 50 l
of TE buffer. For 48S isolation, lysates were centrifuged
on a 10–35% sucrose gradient at 45 000 rpm for 3 h in
an SW50.1 rotor. For protein analysis, samples were di-
gested with RNAse A and T1 for 1 h at 37◦C before sodium
dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) analysis. For RNA analysis of crosslinking prod-
ucts, samples were digested with proteinase K and RNA
was extracted twice with phenol and then precipitated in
ethanol. RNase H assays were carried out as described pre-
viously (21). Briefly, samples were annealed at 65◦C for 5′
with 10 pmol of oligonucleotides covering the indicated re-
gions of 18S rRNA and digested with 5 U of RNase H
(NEB) for 15 min at 37◦C. Finally, the samples were ana-
lyzed by denaturing agarose gel electrophoresis, transferred
to nitrocellulose membrane and exposed to X-ray films.
Denaturing immunoprecipitation
The ribosomal fraction from a 500 l translation reaction
including 2 g of [-32P]-4-thio-U- SV-DLP U1 mRNA
and GMP-PNP was obtained as described above and de-
natured in a buffer containing Tris–HCl 50 mM pH 7.4, 5
mM EDTA, 10 mM dithiothreitol (DTT) and 5% w/v SDS
as described previously (27). After 5 min boiling, samples
were kept on ice and slowly renatured by 10-fold dilution in
Tris-HCl 50 mM pH 7.4, 150 mM NaCl, 5 mM ethylenedi-
aminetetraacetic acid (EDTA) and 1% Triton X-100. Then,
the extract was divided in two parts, incubated either with
-eIF4A antisera (St John’s lab, STJ27247) or -RPS6 (St
Cruz) O/N at 4◦C. Next, a mixture of protein A/G con-
jugated to magnetic beads (Thermo Fisher Scientific) was
added and incubated for an extra hour at RT, and immuno-
precipitated complexes were analyzed by SDS-PAGE and
autoradiography.
Toeprinting assays
Toeprinting analysis was carried out essentially as described
previously (28). Each 10-l reaction contained 7.5 l of
rabbit reticulocyte lysates (RRL) (Promega) and either 2
mM of GMP-PNP (for 48S assembly) or 0.8 g/l of cy-
cloheximide (for 80S assembly), with the final magnesium
acetate concentration adjusted to 2.5 and 1 mM, respec-
tively. Lysates were pre-incubated for 10 min at 30◦C, and
150 ng of capped mRNAs were added and incubated for an
additional 20 min at 30◦C. Then, an equal volume of RT
mix containing 0.5 mM dNTP mix, 1× RT buffer, 5 mM
DTT, 10 pmol VIC-labeled capsid primer (24) and 200 U of
SuperScript™ III RT enzyme (Invitrogen) were added and
samples were incubated at 37◦C for 40 min. At this temper-
ature, we found that RT proceeded through the DLP struc-
ture without any extension arrest. Finally, samples were ex-
tracted twice with phenol/chloroform/IAA, ethanol pre-
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Figure 1. Analysis of proteins crosslinked to DLP mRNA in 48S complexes assembled in RRL. (A) Schematic diagram of the assembled 48S complex on
mRNA showing a DLP structure located at 28 (SV) and 31 (SFV) nt downstream from the AUG. Four different mRNAs were used, containing 4-thio-U
residues at the indicated positions (black dots). (B) Crosslinking of [32P]-labeled SV-DLPU1 mRNA with proteins of the 48S complex analyzed from crude
ribosomal fraction (P100). Where indicated, the lysates were irradiated or not with UV (right panel), and treated or not with 10 g of proteinase K for 30
min before analysis (middle panel). The right panel shows a crosslinking experiment programmed with SV-DLP U1 or SV-DLP U1 mRNAs. In all cases,
samples were extensively digested with RNAses and analyzed by SDS-PAGE followed by autoradiography as described in ‘Materials and Methods’ section.
(C) Crosslinking of [32P]-labeled SV-DLPU1 mRNA in 48S complexes isolated by sucrose gradient centrifugation. The fractions analyzed are marked with
arrowheads. (D) Crosslinking patterns using the indicated mRNAs in the 48S complex (by GMP-PNP) or in the 80S complex (by cycloheximide). Note
that the p48 band was only detected in 48S complexes assembled with DLP-containing mRNA, bearing 4-thio-U at the base of DLP structure.
Probing and modeling RNA structures
SHAPE (selective 2′-hydroxyl acylation and primer ex-
tension) was used for probing RNA structure with N-
methylisatoic anhydride (NMIA) that reacts with unpaired
nucleotides of RNA (29). Approximately 5 pmol of RNA
was treated with 5–16 mM NMIA (Invitrogen) for 45
min at 37◦C, precipitated with isopropanol and retrotran-
scribed with Superscript III (Invitrogen) using 5′-labeled
[−32P] DLP′s-3′ primer. In parallel, RNA was retrotran-
scribed with 1 mM ddNTPs/1 mM dNTPs for sequenc-
ing. Fragments were analyzed in 10% acrylamide-urea gels
and bands were quantified by densitometry and normal-
ized. SHAPE data were used as constraints to generate
2D and 3D models using the MC-fold and RNAComposer
pipelines (21). RNAfold (Vienna RNA Web Services) was
routinely used to calculate the minimal folding energy of
centroid RNA structures and base pair probabilities.
In vitro translation
In vitro translation was performed in nuclease-treated RRL
(Promega) using 150 ng of capped SV DLP-capsid or SV
DLP-capsid mRNAs in the presence of 15 Ci of [35S]-
Met for 60 min at 30◦C. Samples were denatured in sample
buffer and analyzed by SDS-PAGE and autoradiography as
described previously (24).
Western blot and immunofluorescence
Western blots were carried out as described previously (24)
using the following primary antibodies: -myc (Clontech),
-SV E1, -SV C, -eIF2 (Santa Cruz Biotech.), -RPS7
(Santa Cruz Biotech.), -RPS2 (Santa Cruz Biotech.), -
RPS6 (Santa Cruz Biotech.), mouse -eIF4A (a gift of
M. Altmann, University of Bern, Switzerland) and rabbit
-eIF4A (St John’s lab, STJ27247). Blots were developed
with ECL (GE) and bands were quantified by densitome-
try. Immunofluorescence (IF) analysis was carried out as de-
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Figure 2. eIF4A interacts with the base of the DLP RNA in the 48S complex. (A) Crosslinking assays using SV-DLP U1 and SFV-DLP U1 mRNAs
in the presence of hippuristanol or polyI:C. Samples were treated with 1 M of hippuristanol or 0.5 ng/l poly I:C to block eIF4A or to induce eIF2
phosphorylation, respectively, as indicated. Then, P100 fractions were obtained and equivalent cpms were analyzed by SDS-PAGE and autoradiography.
The lower panel shows typical eIF2 phosphorylation induced by poly I:C treatment of RRL. (B) Denaturing IP with anti-eIF4A and anti-RPS6 antibodies.
48S complexes were assembled with SV-DLP U1 mRNA, crosslinked and the WRF was denatured and subjected to IP with the indicated antibodies (as
described in ‘Materials and Methods’ section).
and mouse -eIF4A (1:20) as primary antibodies, and -
mouse Alexa 488 or -rabbit Alexa 595 as secondary an-
tibodies (Invitrogen). The preparations were analyzed in a
Zeiss Axioskop 2 plus fluorescence microscope.
Immunoelectron microscopy
To locate eIF4A in the 48S complex, 300 l of RRL were
incubated with 0.2 and 3 g of fluorescein-labeled and unla-
beled SV-DLP U1 mRNA, respectively, and 48S complexes
were allowed to assemble in the presence of GMP-PNP as
described above. Then, lysates were fixed on ice with 1%
formaldehyde for 20 min and quenched with 0.3 M glycine
and Tris–HCl 50 mM pH 7.5. The lysates were centrifuged
in a 10–35% sucrose gradient for 2.5 h at 40 000 rpm in a
Beckman SW50 rotor and fractionated from the bottom.
The peak 48S fraction was identified by measuring the fluo-
rescence of fractions incubated with 1:25 -eIF4A (St John’s
lab, STJ27247) antibody for 3 h at 4◦C. Then, ribosomal
complexes were sedimented at 90 000 rpm for 90 min in a
TLA100.1 rotor, resuspended in 50 l of polysome buffer
and incubated for 90 min at 4◦C with a 1:100 dilution of 5
nm colloidal gold-labeled protein A (GPA, University Med-
ical Center Utrecht). To locate mRNA region downstream
of AUG within the 48S complex, we used SV DLP U1
mRNA bound to a 5′-biotinylated RNA oligo (AAGGUA
AUGGUCGUCGUCCG) that hybridizes in the region 25–
45 nt of the mRNA coding sequence (CDS). Finally, sam-
ples were negatively stained for electron microscopy anal-
ysis. The samples were visualized in a Tecnai 12 transmis-
sion EM (FEI, Netherlands) or in a Jeol 1230 operating at
120 and 100 keV, respectively. Images were recorded on a
TVIPS CMOS camera at 61 320 × nominal magnification
(2.5 Å/pixel). Only labeled particles whose orientation were
unambiguously determined by two-axis measurement were
selected and grouped into similarity classes.
RESULTS
Crosslinking of eIF4A and mRNA within the 48S complex
We recently used minimal versions of SV and SFV 26S mR-
NAs labeled with photoreactive 4-thio-U residues to de-
tect the interaction of the DLP with the solvent side of
48S complex (21). Analysis of RNA–RNA crosslinking re-
vealed specific contacts between the DLP base (SV and SFV
U1 mRNAs) and regions of 18S rRNA located on the sol-
vent side, including the ES6S and h16–18 helices (21). In
order to extend to other components of 48S complex, we
analyzed protein crosslinking with [32P]-SV mRNA U1 in
the presence of GMP-PNP, a non-hydrolyzable GTP ana-
log that freezes 48S PIC upon initiation codon recogni-
tion (late stage initiation complex) (Figure 1A). Proteins
that are contacting SV and SFV mRNAs within initia-
tion complex can be crosslinked to photoreactive 4-thio-U
residues placed at the indicated positions in the mRNAs,
and then analyzed upon extensive digestion of complexes
with RNAses. 48S complexes were assembled in RRL and
analyzed directly from the ribosomal P100 fraction (Figure
1B), or further separated by centrifugation in sucrose gra-
dients (Figure 1C). SDS-PAGE analysis revealed at least
two prominent protein bands in the range of 48–50 kDa,
that crosslinked with the DLP base of 48S, and two addi-
tional fainter bands of 32 and 75 kDa whose intensity var-
ied among RRL batches (Figure 1B). SV and SFV mR-
NAs generated a similar pattern of protein crosslinking,
whereas neither p48 nor p32 bands were detected when a
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Figure 3. eIF4A crosslinking with SV mRNA is DLP position dependent. (A) Variants of SV-DLP U1 mRNA where the distance from the AUG was
shortened (d = 19) or extended (d = 37) were used. Quantification of eIF4A crosslinking from three independent experiments (mean ± SEM) is shown
in the bottom panel. (B) Model of 43S complex bound to mRNA showing the approximate positions of DLP structures at d = 19, 28 and 37, assuming
that mRNA penetrates through the ES6SA and ES6SB helices of the 40S subunit. The positions of eIF3 and the ternary complex (TC) are also shown.
(C) Translation activity of DLP structures located 19, 28 and 37 nt from the AUG. Recombinant virus expressing an EGFP reporter mRNA (SV-EGFP)
bearing the DLP structure located at the indicated position (d) or lacking it (−) were obtained and described previously (21). 3T3 cells were infected with
the indicated viruses at an MOI of 10, extracts were made at 6 hpi and analyzed by western blot with the indicated antibodies.
ure 1B). Moreover, no crosslinking of p48 was detected
when 4-thio-U was placed in the middle and apical region
of DLP structure (SV DLP U2 mRNA), showing that this
protein contacted only the nucleotides flanking the base of
the DLP (Figure 1D). We next compared the patterns of
protein crosslinking in 48S and 80S complexes by using cy-
cloheximide instead of GMP-PNP to block the 80S initia-
tion complex at the pre-translocation step (30). As shown
in Figure 1D, the p48 band was not detected in 80S com-
plexes assembled with SV or SFV U1 mRNAs, whereas
p52 was even enriched in the 80S complex in some cases.
The size and behavior of the 48 kDa band (p48) resembled
eIF4A, the main RNA helicase of 48S complex that asso-
ciates with eIF4G (11). To verify this, we first used hippuris-
tanol, a potent and highly specific inhibitor of the RNA
binding and helicase activities of eIF4A (31). Addition of
hippuristanol to translation mixtures decreased the inten-
sity of the 48 kDa band in a specific manner (Figure 2A),
confirming that it was indeed eIF4A. To further confirm
this point, we carried out denaturing immunoprecipitation
(IP) of crosslinked lysates using an anti-eIF4A antibody. Be-
fore IP, the lysates were denatured by SDS treatment to pre-
vent accidental co-precipitation of associated proteins. As
shown in Figure 2B, the 48 kDa band was specifically im-
munoprecipitated by anti-eIF4A antibodies.
We next carried out similar experiments using -globin
mRNA to assemble the 48S complex. -globin mRNA
lacks a DLP-like structure, but it contains only a single ade-
nine in the 27–51 region of the CDS, which allowed us to de-
sign an RNA probe lacking internal uracils. Once annealed
to the -globin mRNA, this probe mimicked the stem part
of the SV DLP RNA structure and had comparable sta-
bility (Supplementary Figure S1A). It also contained two
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Figure 4. Effect of VIColigo-4 on the interaction of eIF4A in the 48S complex with the base of the DLP structure. (A) 43S model showing the binding
site of VIColigo-4 to the ES6SC-D helix. VIColigo-4 binding to purified rabbit 40S subunit was analyzed by RNAse H cleavage as described previously
(21). The resulting 18S rRNA fragments were analyzed by electrophoresis in a 0.8% agarose gel. (B) Effect of VIColigo-4 addition (10 M) on translation
programmed with SV DLP capsid and SV DLP capsid mRNAs in RRL. Note that elimination of the DLP structure impaired AUG recognition, giving
rise to aberrant products (gray arrowheads) that resulted from spurious initiation at downstream AUGs, as reported previously (24). (C) Crosslinking
assays using SV DLPU1 mRNA in the presence of 10 M of VIColigo-4. Ribosomal fractions (P100) and post-ribosomal fractions (S100) were analyzed.
The change in intensity of the eIF4A band was measured from three independent experiments; data are represented as the mean ± SEM. (D) Effect of
VIColigo-4 on 48S formation and eIF4A crosslinking. The experiment was performed as in Figure 1C; as VIColigo-4 reduced 48S formation, the volume of
fraction 11 was adjusted to analyze an equivalent cpm. Arrows shows the direction of sedimentation.
that they placed at positions 27–28 of -globin mRNA. We
found that crosslinking efficiency of -globin mRNA:probe
was lower compared to SV and SFV mRNAs, probably be-
cause photoreactive 4-thio-U residues are not placed di-
rectly in the -globin mRNA, but in the probe (Supple-
mentary Figure S1A). Notably, probe:-globin mRNA gen-
erated a pattern of protein crosslinking that included two
bands of similar size to p48 (eIF4A) and p32 (Supplemen-
tary Figure S1B). In addition, this crosslinking revealed two
specific bands (p42 and p80) that were not visible in SV DLP
RNA samples. The identity of eIF4A was confirmed by de-
naturing IP, showing that eIF4A in the 48S complex can
also contact AUG-downstream regions of cellular mRNA.
The identity of p42 and p80 bands, and whether p80 is re-
lated to p75 band observed in complexes assembled with SV
and SFV mRNAs, are unknown.
eIF4A acts on the ES6S region of the 40S subunit
Subsequent experiments were designed to identify the re-
gion of 40S where eIF4A contacts the DLP of SV mRNA.
As a first approach, we compared the crosslinking patterns
generated by SV DLP U1 mRNAs where DLP-AUG dis-
tance (d) were shortened to 19 nt or lengthened up to 37 nt.
We previously found that DLP activity was strictly position
dependent, showing a window of activity 25–50 nt down-
stream from the AUG (21). eIF4A crosslinking to d = 19
and d = 37 mRNAs was clearly reduced when compared to
wild-type (WT) mRNA (d = 28), although d = 37 mRNA
still retained 20–30% of WT levels (Figure 3A). It is im-
portant to note that the sequences flanking the DLP struc-
ture, as well the position of 4-thio-U are identical in these
three mRNAs. Moreover, RNA folding programs predicted
no alteration in the overall DLP structure in these mRNAs.
Modeling of d = 19 mRNA in the 48S complex showed that
the DLP structure is likely placed above ES6S region, prob-
ably near the mRNA entry channel (Figure 3B). Modeling
of d = 37 mRNA, however, was compatible with DLP be-
ing placed on ES6S region, although stable interaction of
photoreactive 4-thio-U residues with 18S rRNA was lost in
both d = 19 and d = 37 mRNAs when compared to WT
mRNA (Figure 3A and Supplementary Figure S2). These
results show that eIF4A crosslinking depended on DLP po-
sition on the solvent side of the 40S subunit, suggesting that
eIF4A may act on the ES6S region. It is important to note
that d = 19 mRNA was unable to support translation in
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translation similar or superior to WT mRNA (Figure 3C),
suggesting that eIF4A crosslinking observed in vitro did not
parallel translation of SV mRNA in infected cells.
Next, we analyzed the effect of a previously described
synthetic oligonucleotide (VIColigo 4) (21) targeted to
ES6SC helix on eIF4A crosslinking (Figure 4A). We pre-
viously reported that binding of VIColigo 4 to the 40S sub-
unit inhibited translation of SV and SFV mRNA in infected
cells (21), presumably by blocking the channel that extends
between the ES6SA and ES6SC-D helices (Figure 4A). Pre-
incubation of RRL with VIColigo 4 inhibited translation of
SV capsid mRNA that was detected by [35S]Met labeling
and autoradiography (Figure 4B), similar to that observed
in infected cells (21). Furthermore, the observed reduction
in 48S complex formation by VIColigo 4 suggested that the
ES6S region of 40S could be involved in SV mRNA attach-
ment. Of note, pre-incubation with VIColigo 4 drastically re-
duced the crosslinked eIF4A band detected in crude riboso-
mal fractions (P100) and 48S peak (Figure 4C and D), rein-
forcing the notion that ES6S is involved in eIF4A–mRNA
contact.
Despite the high stability of the base of the DLP struc-
ture in SV and SFV mRNAs (G◦ = −20–30 kcal.mol−1),
which exceeds the unwinding capability of eIF4A helicase
(12,14), we wanted to test if a fraction of DLP stalled in the
ES6S region could be effectively unwound by eIF4A. Thus,
we compared the crosslinking of SV-DLP with 18S rRNA
in the absence or in the presence of hippuristanol. We previ-
ously reported that the DLP contacts both the ES6S region
and h16–h18 helices of 18S rRNA within the 48S complex,
and that these contacts can be distinguished by an RNAse
H assay using oligo 5.1 followed by separation in denaturing
agarose gels (21). Inhibition of eIF4A activity increased the
band intensity corresponding to mRNA crosslinked with
the ES6S region (nt 680–830) of 18S rRNA, with a con-
comitant decrease in the band crosslinked with the h16–h18
region (nt 509–663) (Figure 5A). This can be interpreted as
unwinding by eIF4A that releases a fraction of DLP struc-
tures from ES6S, leading to subsequent accumulation of
DLP near the h16. To confirm this, we tested the effect of
hippuristanol on toeprinting assays using a condensed ver-
sion of SV 26S mRNA (see ‘Materials and Methods’ sec-
tion). In the assembled 48S complex, primer extension by
RT is typically arrested at 15–17 nt of mRNA, a result that
has been used to roughly mark the leading edge of the 40S
subunit into the scanning PIC (32–34). However, structural
and biochemical data from synthetic mRNA threaded in
the 40S binding cleft showed that the entry channel is ∼11
nt from the AUG of mRNA, showing that RT cannot pen-
etrate completely in the entry channel (18,35,36). For 48S
complexes assembled with SV DLP-capsid mRNA, in addi-
tion to the standard toeprints at 17–19 nt, we also detected
minor arrests at 23–26 and 7–8 nt (Figure 5B). Toeprints at
23–26 nt may be suggestive of downstream interactions of
mRNA with ES6S components of the 48S complex, whereas
aberrant arrests at 7–8 nt have been interpreted as the result
of incomplete mRNA threading into the 40S binding cleft
(37). Importantly, toeprints at 23–26 nt were not detected in
complexes assembled with SV DLP capsid mRNA (Fig-
ure 5B), showing that these toeprints required DLP to stall
in the ES6S region. Interestingly, hippuristanol treatment
increased the proportion of toeprints at 23–26 nt and re-
duced the proportion of toeprints at 17–19 nt (Figure 5B),
consistent with the notion that eIF4A indeed promotes the
release of a fraction of unwound DLP from a region that
was responsible for toeprints at 23–26 nt. This also implies
that a substantial fraction of toeprints at 17–19 nt resulted
from eIF4A-mediated release of DLP from downstream re-
gions. We also observed that toeprints at 7–8 nt were also in-
creased by hippuristanol treatment, suggesting that eIF4A
activity is probably required for proper threading of mRNA
in vitro.
To visualize eIF4A in 48S particles, we carried out im-
munogold labeling of eIF4A followed by EM using com-
plexes assembled with SV-DLP U1 mRNA in RRL. Gra-
dient fractions were first examined for the presence of as-
sociated eIFs, showing that the 48S peak contained eIF4A,
eIF3 and eIF2 as expected (Figure 6A). Negative staining
EM of peak 48S fractions also revealed the presence of con-
taminating 60S and isolated 40S subunits as described re-
cently (38) (Supplementary Figure S3A). Next, the peak
48S fraction was incubated with an anti-eIF4A antibody,
followed by incubation with 5 nm gold-coated protein A
(GPA). Gold labels corresponding to eIF4A were detected
in ∼5–10% of the total particles, whereas stochastically few
labels were observed when primary antibodies were omit-
ted, showing the specificity of the labeling (Supplementary
Figure S3B). The low efficiency in the labeling could be re-
flecting a real occupancy of eIF4A on 40S subunits, or it
could be attributable to the low accessibility of antibodies
or/and GPA to the 40S subunit loaded with mRNA and
eIFs. Assuming that labels are spaced up to 17 nm from the
antibody-binding site (39), the gold would be the center of
a 17 nm-radius circle containing the antigen. We selected
and analyzed 20 particles whose projections were identified,
showing that eIF4A labels were concentrated in the solvent
side of 40S. In about half of these particles, gold labels were
located between eIF3 and the 40S body (class I), whereas
the rest of the particles had gold near the feet (30%, class
II) or the beak of the 40S head (15%, class III). Interest-
ingly, we found some particles where two gold labels corre-
sponding to eIF4A were detected (Figure 6B). To comple-
ment this result, we mapped the position of gold bound to
SV DLP mRNA on the 48S complex. For this, we designed a
5′-biotinylated RNA oligo targeted to 25–37 nt downstream
of the AUG of SV DLP U1 mRNA that mimics the natu-
ral DLP structure (Supplementary Figure S3C). We roughly
estimate that the streptavidin-nanogold particle bound to
the biotinylated oligo is extended 6–10 nm from the 5′ end
of the oligo, although in this case an accurate measurement
of the spacing was impossible. Analysis of the peak 48S frac-
tion revealed labels in ∼10% of total particles concentrated
on the solvent side of the 40S subunit near the feet, although
we also detected some particles with labels near the classi-
cal mRNA entry channel, or even below the beak of the 40S
subunit (Figure 6C). In both types of labeling, we also de-
tected additional particle densities on the solvent side that
could be attributable to antibody and/or the presence of
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Figure 5. eIF4A activity within the 48S complex. (A) RNase H-mapping of RNA–RNA interactions between SV-DLP U1 and 18S rRNA. The analysis
was carried out in the absence or presence of 1 M hippuristanol, with identification of the resulting RNA fragments indicated. For clarity, a schematic
diagram of the ES6S and h16–18 regions of rabbit 18S rRNA with the primers used for RNase H digestion is shown. The use of oligos 4 and 9 limited the
region of 18S rRNA (509–830) where the crosslinkings concentrated. Bands corresponding to crosslinking of SV DLP U1 mRNA with the ES6S region
(680–1863) and h16-h18 helices (1–662) were quantified by densitometry and expressed as a ratio. Data are the mean ± SEM from four independent
experiments. (B) Effect of eIF4A inhibition on 48S toeprinting generated by SV-DLP U1 and SV-DLP U1 mRNAs. Assays were carried out in the
absence of presence of 1 M of hippuristanol; positions of resulting primer extensions are annotated with respect to the A (+1) position of AUG, and
they have been assigned with a precision of ±1 nt. The bottom shows a 2D structural model of the first 100 nt of 26S mRNA, showing the secondary
structure derived from SHAPE analysis (21). Reactivity to SHAPE reagent (NMIA) is higher for unpaired nucleotides (red) and low for those involved in
pairings (black). Stops corresponding to toeprints are marked with arrowheads. Quantification of toeprint ratios (17–19/23–25) in absence or presence of
hippuristanol is shown from three independent experiments; data are the mean ± SEM.
eIF4A activity is detrimental to translation of SV mRNA in
infected cells
Since DLP integrity is essential for eIF2-independent trans-
lation of SV mRNA in infected cells (21,24), it was thought
that eIF4F-mediated unwinding of SV DLP RNA could be
detrimental to viral mRNA translation in mammalian cells.
Previous studies have reported that translation of SV 26S
mRNA in infected cells shows low dependence on eIF4F ac-
tivity (40). Moreover, exclusion of some eIFs (eIF2 and 4F)
from viral factories has been reported in infected cells. To
confirm this, we analyzed the distribution of eIF4A in SFV-
infected cells by means of IF, showing a dramatic exclusion
of eIF4A from viral factories with active translation of vi-
ral mRNAs (Figure 7A). Given this exclusion, the eIF4A
activity outside the viral factories is expected to have a min-
imal impact on DLP-dependent translation in infected cells,
which prompted us to test the effect of forced eIF4A expres-
sion within viral factories by using recombinant SV that en-
code human eIF4A (see ‘Materials and Methods’ section).
As is shown in Figure 7B, accumulation of recombinant
eIF4A co-localized with viral capsid proteins, representa-
tive of viral factories (41). Viruses expressing eIF4A showed
a 60–70% reduction in the synthesis of viral proteins, indi-
cating that ectopic expression of eIF4A in viral factories in-
terfered with translation of SV 26S mRNA.
DISCUSSION
During adaptation to the host, viruses often find simple so-
lutions to better translate their mRNAs in a manner less de-
pendent on eIFs. In some cases, these viral tricks have been
used to infer the function of eIFs in canonical initiation, a
task that has also required the analysis of viral translation
outside of infected cells (42). For SV and SFV 26S mRNA,
the acquisition of a stable DLP structure in mRNA emerged
as a solution to locate the start AUG when eIF2 becomes
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Figure 6. EM localization of eIF4A and mRNA in the 48S complex. (A) Analysis of the eIF composition of 48S complexes assembled with SV-DLP
U1 mRNA. A small amount of fluorescein-labeled SV-DLP U1 mRNA was included in the reaction to identify the fraction corresponding to 48S peaks.
Fractions 6–12 were precipitated in acetone–chloroform and analyzed by western blot using the indicated antibodies. Fractions 8–10 were pooled and
subjected to immuno-EM using an -eIF4A antibody followed by incubation with 5 nm GPA. (B) Gallery of most abundant views grouped into three
classes. Photographs were taken at 60K (except otherwise indicated) and the corresponding projections on the 43S model (EM-5658) are shown Scale bar
corresponds to 10 nm. (C) Gallery of most abundant views of the 48S complex assembled with SV DLP mRNA bound to a 5′-biotinylated antisense
RNA oligo (see Supplementary Figure S3C for details). In this case, the samples were incubated with streptavidin-5 nm gold as described in the ‘Materials
and Methods’ section. (D) Superposition of all labels for eIF4A (red) and for mRNA (green), showing the most likely placement areas.
different in RRL programmed with SV mRNA, since these
extracts contain high concentrations of ribosomes and fully
active eIFs (43). Here, using RRL to assemble 48S com-
plexes with SFV and SV mRNAs free of any viral interfer-
ence, we were able to detect for the first time the interaction
of eIF4A within the 48S complex with nucleotides located
downstream from the start AUG. This interaction was only
detected when the crosslinkable residues were placed flank-
ing the DLP structure of the mRNA, suggesting that the
stability of the DLP base was great enough to jam a frac-
tion of eIF4A molecules on the mRNA. This conclusion is
consistent with the limits on unwinding activity previously
estimated for eIF4A (G◦ = −20–30 kcal.mol−1) by using
helicase assays in vitro with RNA duplex substrates (12,44).
The binding of eIF4A to single stranded flanking the DLP
structure agrees well with previous reports showing a strong
preference of yeast eIF4F for a single stranded region to
unwind duplex RNAs (45), although a similar preference
was not observed in mammalian eIF4F (44,46). Whether
eIF4A enters as free molecule or as part of eIF4F complex
in 48S complex assembled with SV and SFV mRNAs is un-
known. Nonetheless, in RRL programmed with SV mRNA
we found considerable unwinding activity by eIF4A on SV
DLP-ES6S, an interaction that was attenuated by hippuris-
tanol treatment, suggesting that eIF4A probably releases a
fraction of mRNA molecules from the ES6S region, lead-
ing to the appearance of new contacts with upper regions
of rRNA (h16 and h18) in the 48S complex. This detrimen-
tal effect that eIF4A has on DLP stability and viral mRNA
translation offers a convincing causative explanation for the
exclusion of eIF4F from viral factories observed in infected
cells, and illustrates an example of how a game of RNA sta-
bility played between the virus and host resulted in transla-
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Figure 7. Ectopic expression of eIF4A in viral factories reduced SV mRNA translation. (A) Exclusion of eIF4A from SFV viral factories. IF of eIF4A
in mock and SFV-infected cells, with SFV C protein stained in red and eIF4A in green. Note the exclusion of eIF4A from viral factories as revealed by
C protein staining (arrowheads). About 75% of analyzed cells showed this pattern, and a representative field is shown. (B) Schematic representation of
recombinant SV expressing human eIF4A-myc. Cells were infected with two independent SV-eIF4A clones and analyzed by western blot against myc
epitope (right upper panel), by IF against SV C and myc epitopes (left lower), and by metabolic labeling with [35S]-Met. The position of viral protein bands
is indicated; in all cases, samples were analyzed at 6 hpi, with two SV clones expressing EGFP used as controls.
whether the lack of eIF4A in viral factories involves active
removal of eIF4F or simply its exclusion from the 40S-eIF3
complexes that are concentrated within viral factories (41),
so further studies are required to clarify this point.
The detection of toeprints at nt 23–25, whose relative in-
tensity increased upon hippuristanol treatment, reinforces
the idea that eIF4A is acting on the ES6S region of 40S, con-
verting the incoming mRNA into a single-stranded form
during its approach to the entry channel to give the canon-
ical toeprints at 17–19 nt. Interestingly, recent analysis of
initiation complex-specific ribosome footprints in yeast has
revealed that, in addition to the main +16 nt protection,
mRNA is also protected at +25 nt from the AUG, a find-
ing that nicely agrees with data presented here if we as-
sume that mRNA is threaded into the ES6S region before
reaching the classical mRNA entry channel (47). Thus, the
interaction of flanking nucleotides of the DLP structure
with the ES6S region that we reported recently could eas-
ily explain the RT stops at 23–25 nt found here (21). The
crosslinking of SV and SFV mRNAs with both exposed
(helices A and B) and inner ES6S segments (helix C and
D) suggests that these mRNAs could be penetrating the
ES6S region (21,22), a notion that is further supported by
the inhibitory effect of with VIColigo 4 on translation of
SV 26S mRNA observed in cultured cells (21) and in RRL
shown here. The results using VIColigo 4, or when moving
the DLP structure upstream by 9 nt (equivalent to 40 Å)
further support the notion that the eIF4A helicase, proba-
bly as part of the eIF4F complex, is placed on (or near) the
ES6S region of the 40S subunit during scanning. This loca-
tion agrees well with data showing that the middle domain
of eIF4G (eIF4G-MD) contacted with ES6SE and ES6SB
projections of 40S when initiation complexes were assem-
bled in the presence of viral mRNA (48), and by a recent
report showing that mRNA attachment occurs on the sol-
vent side of 40S through a chain of interactions that involves
eIF4F and eIF3 (3). Our data also support short-range ac-
tivity for eIF4A since its interaction with the base of the
DLP was dependent on DLP-AUGi spacing. Perhaps most
eIF4A molecules in 43S–mRNA complexes are immobi-
lized via interaction with eIF4G, although the low (but still
detectable) level of crosslinking of eIF4A to the base of DLP
d = 19 is compatible with a small fraction of eIF4A acting
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Figure 8. Model of PIC scanning. (A) Canonical model of PIC scanning with eIF4F complex placed on ES6S region of 40S subunit (EM-5658) (19),
interacting with both 3′and 5′regions of mRNA (orange). The scaffolding eIF4G factor is in yellow, interacting with both ES6S (48) and eIF3 as reported
before (49,50). In this model two molecules of eIF4A (red rollers) are placed on eIF4G according to previous data (13,15). The 4E subunit of eIF4F (eIF4E)
is dissociated from the cap structure upon 48S complex formation as suggested recently (3). (B) SV DLP-mediated stalled PIC showing one eIF4A molecule
jammed by DLP structure on ES6S region. The rest of factors and details were omitted for simplicity. The position of VIColigo-4 is also shown (red).
molecules of eIF4A could be acting within the 48S complex
in a coordinated manner, acting one of them in a diffusible
manner (Figure 8A) (15). The presence of two gold labels
found in some 48S particles when staining for eIF4A by EM
could support this possibility.
Taken together, data presented here supports a model
where the eIF4F complex is working at the leading edge of
the scanning PIC, rather than acting as a simple clamp to
prevent backsliding as suggested previously (16). Nonethe-
less, the extended topology that eIF4G presumably adopts
could promote simultaneous binding of eIF4F to the 5′ and
3′ ends of mRNA, bringing the two ends of mRNA near the
body of 40S in a way that could allow an eIF4A/4B tandem
working on the front (3′-pulling) and back (5′-pushing) in a
coupled manner (15,49,50).
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